» Articles » PMID: 34295915

Original Hosts, Clinical Features, Transmission Routes, and Vaccine Development for Coronavirus Disease (COVID-19)

Overview
Specialty General Medicine
Date 2021 Jul 23
PMID 34295915
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The pandemic of coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to public concern worldwide. Although a variety of hypotheses about the hosts of SARS-CoV-2 have been proposed, an exact conclusion has not yet been reached. Initial clinical manifestations associated with COVID-19 are similar to those of other acute respiratory infections, leading to misdiagnoses and resulting in the outbreak at the early stage. SARS-CoV-2 is predominantly spread by droplet transmission and close contact; the possibilities of fecal-oral, vertical, and aerosol transmission have not yet been fully confirmed or rejected. Besides, COVID-19 cases have been reported within communities, households, and nosocomial settings through contact with confirmed COVID-19 patients or asymptomatic individuals. Environmental contamination is also a major driver for the COVID-19 pandemic. Considering the absence of specific treatment for COVID-19, it is urgent to decrease the risk of transmission and take preventive measures to control the spread of the virus. In this review, we summarize the latest available data on the potential hosts, entry receptors, clinical features, and risk factors of COVID-19 and transmission routes of SARS-CoV-2, and we present the data about development of vaccines.

Citing Articles

Self- and informant-reported personality traits and vaccination against COVID-19.

Arumae K, Realo A, Ausmees L, Allik J, Esko T, Fischer K PLoS One. 2024; 19(3):e0287413.

PMID: 38483965 PMC: 10939290. DOI: 10.1371/journal.pone.0287413.


CO Concentrations and Thermal Comfort Analysis at Onsite and Online Educational Environments.

Alegria-Sala A, Cleries Tardio E, Canals Casals L, Macarulla M, Salom J Int J Environ Res Public Health. 2022; 19(23).

PMID: 36498111 PMC: 9739221. DOI: 10.3390/ijerph192316039.


Can the COVID-19 Pandemic Improve the Management of Solid Organ Transplant Recipients?.

Del Bello A, Marion O, Izopet J, Kamar N Viruses. 2022; 14(9).

PMID: 36146666 PMC: 9500961. DOI: 10.3390/v14091860.


The CRISPR-Cas system as a tool for diagnosing and treating infectious diseases.

Lou J, Wang B, Li J, Ni P, Jin Y, Chen S Mol Biol Rep. 2022; 49(12):11301-11311.

PMID: 35857175 PMC: 9297709. DOI: 10.1007/s11033-022-07752-z.


Rational identification of small molecules derived from 9,10-dihydrophenanthrene as potential inhibitors of 3CL enzyme for COVID-19 therapy: a computer-aided drug design approach.

Daoui O, Elkhattabi S, Chtita S Struct Chem. 2022; 33(5):1667-1690.

PMID: 35818588 PMC: 9261181. DOI: 10.1007/s11224-022-02004-z.


References
1.
Doung-Ngern P, Suphanchaimat R, Panjangampatthana A, Janekrongtham C, Ruampoom D, Daochaeng N . Case-Control Study of Use of Personal Protective Measures and Risk for SARS-CoV 2 Infection, Thailand. Emerg Infect Dis. 2020; 26(11):2607-2616. PMC: 7588529. DOI: 10.3201/eid2611.203003. View

2.
Wu Z, McGoogan J . Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323(13):1239-1242. DOI: 10.1001/jama.2020.2648. View

3.
Muus C, Luecken M, Eraslan G, Sikkema L, Waghray A, Heimberg G . Single-cell meta-analysis of SARS-CoV-2 entry genes across tissues and demographics. Nat Med. 2021; 27(3):546-559. PMC: 9469728. DOI: 10.1038/s41591-020-01227-z. View

4.
Huang I, Bailey C, Weyer J, Radoshitzky S, Becker M, Chiang J . Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011; 7(1):e1001258. PMC: 3017121. DOI: 10.1371/journal.ppat.1001258. View

5.
Chan J, Yuan S, Kok K, To K, Chu H, Yang J . A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395(10223):514-523. PMC: 7159286. DOI: 10.1016/S0140-6736(20)30154-9. View